Google Scholar: cites
Growth differentiation factor 15 as mortality predictor in heart failure patients with non-reduced ejection fraction
Mendez Fernandez, Ana Belen (Institut d'Investigació Biomèdica Sant Pau)
Ferrero-Gregori, Andreu (Institut d'Investigació Biomèdica Sant Pau)
García Osuna, Álvaro (Institut d'Investigació Biomèdica Sant Pau)
Mirabet Pérez, Sonia (Institut d'Investigació Biomèdica Sant Pau)
Pirla-Buxó, Maria Jose (Institut d'Investigació Biomèdica Sant Pau)
Cinca, Juan (Institut d'Investigació Biomèdica Sant Pau)
Ordoñez Llanos, Jorge 1952- (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Roig, Eulàlia (Institut d'Investigació Biomèdica Sant Pau)

Data: 2020
Resum: The prognostic value of biomarkers in patients with heart failure (HF) and mid-range (HFmrEF) or preserved ejection fraction (HFpEF) has not been widely addressed. The aim of this study was to assess whether the prognostic value of growth differentiation factor 15 (GDF-15) is superior to that of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with HFmrEF or HFpEF. Heart failure patients with either HFpEF or HFmrEF were included in the study. During their first visit to the HF unit, serum samples were obtained and stored for later assessment of GDF-15 and NT-proBNP concentrations. Patients were followed up by the HF unit. The main endpoint was all-cause mortality. A total of 311 patients, 90 (29%) HFmrEF and 221 (71%) HFpEF, were included. Mean age was 72 ± 13 years, and 136 (44%) were women. No differences were found in GDF-15 or NT-proBNP concentrations between both HF groups. During a median follow-up of 15 months (Q1-Q3: 9-30 months), 98 patients (32%) died, most (71%) of cardiovascular causes. Patients who died had higher median concentrations of GDF-15 (4085 vs. 2270 ng/L, P < 0. 0001) and NT-proBNP (1984 vs. 1095 ng/L, P < 0. 0001). A Cox multivariable model identified New York Heart Association Functional Class III (P = 0. 04), systolic blood pressure (P = 0. 01), left atrial diameter (P = 0. 03), age >65 years (P < 0. 0001), and GDF-15 concentrations (P = 0. 01) but not NT-proBNP as independent predictors of all-cause mortality. The area under the curve was 0. 797 for the basic model including NT-proBNP, and the area under the curve comparing the overall model was 0. 819, P = 0. 016 (DeLong's test). Integrated discrimination improvement index after the inclusion of GDF-15 in the model with the mortality risk factors was 0. 033; that is, the ability to predict death increased by 3. 3% (P = 0. 004). Net reclassification improvement was 0. 548 (P < 0. 001); that is, the capacity to improve the classification of the event (mortality) was 54. 8%. GDF-15 concentrations were divided in tertiles (<1625, 1625-4330, and >4330 ng/L), and survival curves were evaluated using the Kaplan-Meier technique. Patients in the highest tertile had the poorest 5 year survival, at 16%, whereas the lowest tertile had the best survival, of 78% (P < 0. 001). Growth differentiation factor 15 was superior to NT-proBNP for assessing prognosis in patients with HFpEF and HFmrEF. GDF-15 emerges as a strong, independent biomarker for identifying HFmrEF and HFpEF patients with worse prognosis.
Nota: Altres ajuts: This study was supported by Fundació d'Investigació Sant Pau (G-60136934).
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Matèria: GDF-15 ; HFmrEF ; HFpEF ; Chronic heart failure ; Biomarkers
Publicat a: ESC Heart Failure, Vol. 7 (june 2020) , p. 2223-2229, ISSN 2055-5822

DOI: 10.1002/ehf2.12621
PMID: 32589369


7 p, 415.0 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2021-04-13, darrera modificació el 2023-11-29



   Favorit i Compartir